Refine
Has Fulltext
- yes (10)
Is part of the Bibliography
- yes (10)
Document Type
- Journal article (10)
Language
- English (10)
Keywords
- platelets (3)
- integrins (2)
- ischemic stroke (2)
- platelet activation (2)
- platelet aggregation (2)
- thrombosis (2)
- Activation (1)
- Adipokine (1)
- CD coreceptors (1)
- Cells (1)
- Chemerin (1)
- Chemerin processing (1)
- Cytoskeleton (1)
- GPVI (1)
- Heart (1)
- Identification (1)
- Inflammation (1)
- Metabolism (1)
- Mice (1)
- Peptidase inhibitor 16 (PI16) (1)
- Protease inhibition (1)
- Protein (1)
- Purification (1)
- RARRES2 (1)
- TIG2 (1)
- Zinc (1)
- anti-thrombotic therapies (1)
- antioxidant function (1)
- blood (1)
- blood flow (1)
- blood platelets (1)
- cascade (1)
- cell-cycle arrest (1)
- cerebellum (1)
- collagen (1)
- collagens (1)
- cytotoxic T cells (1)
- damage responses (1)
- dentate gyrus (1)
- embryos (1)
- flow cytometry (1)
- granule cells (1)
- hemostasis (1)
- hippocampus (1)
- homeostasisIon channels (1)
- human (1)
- interactome (1)
- interspecies comparison (1)
- mice (1)
- mouse (1)
- mutant p53 (1)
- network (1)
- neuronal dendrites (1)
- neuronal differentiation (1)
- neurons (1)
- p53-dependent apoptosis (1)
- p53-inducible regulator (1)
- platelet (1)
- proteome (1)
- restoration (1)
- senescence (1)
- serotonin (1)
- signaling (1)
- signalling pathways (1)
- storage-pool diseases (1)
- thrombopoiesis (1)
- transcriptome (1)
- tumorigenesis (1)
Institute
- Rudolf-Virchow-Zentrum (9)
- Institut für Experimentelle Biomedizin (4)
- Theodor-Boveri-Institut für Biowissenschaften (2)
- Institut für Klinische Neurobiologie (1)
- Institut für Medizinische Strahlenkunde und Zellforschung (1)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (1)
- Lehrstuhl für Molekulare Psychiatrie (1)
- Medizinische Klinik und Poliklinik I (1)
- Medizinische Klinik und Poliklinik II (1)
- Neurologische Klinik und Poliklinik (1)
Glycoprotein VI (GPVI) is a platelet-specific receptor for collagen and fibrin, regulating important platelet functions such as platelet adhesion and thrombus growth. Although the blockade of GPVI function is widely recognized as a potent anti-thrombotic approach, there are limited studies focused on site-specific targeting of GPVI. Using computational modeling and bioinformatics, we analyzed collagen- and CRP-binding surfaces of GPVI monomers and dimers, and compared the interacting surfaces with other mammalian GPVI isoforms. We could predict a minimal collagen-binding epitope of GPVI dimer and designed an EA-20 antibody that recognizes a linear epitope of this surface. Using platelets and whole blood samples donated from wild-type and humanized GPVI transgenic mice and also humans, our experimental results show that the EA-20 antibody inhibits platelet adhesion and aggregation in response to collagen and CRP, but not to fibrin. The EA-20 antibody also prevents thrombus formation in whole blood, on the collagen-coated surface, in arterial flow conditions. We also show that EA-20 does not influence GPVI clustering or receptor shedding. Therefore, we propose that blockade of this minimal collagen-binding epitope of GPVI with the EA-20 antibody could represent a new anti-thrombotic approach by inhibiting specific interactions between GPVI and the collagen matrix.